REFRACTORY SOLID TUMOR
Clinical trials for REFRACTORY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMOR trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for kids with resistant cancers
Disease control CompletedThis early-stage trial tested a combination of two drugs—rapamycin and irinotecan—in 42 children and young adults (ages 1–21) with solid tumors that did not respond to standard treatments. The main goal was to find the safest dose and understand side effects. The approach aims to…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for kids with resistant cancers? drug combo shows promise in early trial
Disease control CompletedThis study tested the safety and effectiveness of the drug abemaciclib combined with other cancer medicines in 47 children and young adults whose solid tumors (including neuroblastoma) had stopped responding to standard treatments. The goal was to find the best dose and see if th…
Matched conditions: REFRACTORY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC